TP53 mutations as biomarkers for cancer epidemiology in Latin America: Current knowledge and perspectives

Mutation Research - Reviews in Mutation Research

Volumn 589, Issue 3, 2005, Pages 192-207

  De Moura Gallo, Claudia Vitória ^a   Azevedo E Silva Mendonça, Gulnar ^a   De Moraes, Emanuela ^a,b   Olivier, Magali ^b   Hainaut, Pierre ^b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Biomarkers; Latin America; Molecular epidemiology; TP53 mutation

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P53;

ADRENAL CORTEX CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER; CARCINOGENESIS; CODON; COLON CANCER; DNA POLYMORPHISM; ESOPHAGUS CANCER; GENE MUTATION; GENETIC ANALYSIS; HEAD AND NECK CANCER; HEALTH CARE POLICY; HUMAN; LIFESTYLE; MUTAGENESIS; MUTATION RATE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECTUM CANCER; REVIEW; SOMATIC MUTATION; SOUTH AND CENTRAL AMERICA; TP53 GENE; TUMOR SUPPRESSOR GENE;

ADULT; CHILD; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGIC STUDIES; EPIDEMIOLOGY, MOLECULAR; GENES, P53; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LATIN AMERICA; LIFE STYLE; MUTAGENESIS; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 18144379866     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2005.01.002     Document Type: Review

References (100)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int. J. Cancer 94 2001 153 156
2. D.M. Parkin, S.L. Whelan, J. Ferlay, L. Raymond, and J. Young Cancer incidence in five continents VII 1997
3. D.M. Parkin, S.L. Whelan, J. Ferlay, L. Teppo, and D.B. Thomas Cancer incidence in five continents VIII 2002
4. B. Steward, P. Kleihues (Eds.), World Cancer Report, IARC Press, IARC, 2003.
5. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
6. W.F. Waters Globalization, socioeconomic restructuring, and comunity health J. Community Health 26 2001 79 92
7. C. Albala, F. Vio, and M. Yanez Epidemiological transition in Latin America: a comparison of four countries Rev. Med. Chil. 125 1997 719 727
8. R. Laurenti, C.M. Buchalla, C.A. de Lolio, A.H. Santo, and M.H. Jorge Mortality among women in reproductive age in the municipality of Sao Paulo, Brazil, 1986. II. Deaths by maternal causes Rev. Saude Publica 24 1990 468 472
9. D.M. Parkin, F.I. Bray, and S.S. Devesa Cancer burden in the year 2000. The global picture Eur. J. Cancer 37 Suppl. 8 2001 4 66
10. S. Koifman, and R.J. Koifman Environment and cancer in Brazil: an overview from a public health perspective Mutat. Res. 544 2003 305 311
11. R. Schieri, J.E. Everhart, and G.A. Mendonca Diet and mortality from common cancers in Brazil: an ecological study Cad. Saude Publica 12 1996 53 59
12. F. Wunsch, V.J.E. Moncau, Cancer mortality in Brazil 1980-1995: regional patterns and time trends, Rev. Assoc. Med. Bras. 48 (2002) 250-257.
13. INCA, Dados dos Registros de Cancer de Base Populacional, Rio de Janeiro, 2003.
14. N. Munoz Aspects of gastric cancer epidemiology with special reference to Latin America and Brazil Cad. Saude Publica 13 Suppl. 1 1997 109
15. Sistema de Informação sobre mortalidade, 2004, Ref type: Internet communication.
16. G.A. Mendonca Temporal trends from stomach cancer mortality in Rio de Janeiro State: a comparison between metropolitan area and interior during 1979 and 1986 Cad. Saude Publica 13 Suppl. 1 1997 79 84
17. J. Torres, G. Perez-Perez, K.J. Goodman, J.C. Atherton, B.D. Gold, P.R. Harris, A.M. la Garza, J. Guarner, and O. Munoz A comprehensive review of the natural history of Helicobacter pylori infection in children Arch. Med. Res. 31 2000 431 469
18. A. Verdecchia, A. Mariotto, G. Gatta, M.T. Bustamante-Teixeira, and W. Ajiki Comparison of stomach cancer incidence and survival in four continents Eur. J. Cancer 39 2003 1603 1609
19. E. De Stefani, N. Munoz, J. Esteve, A. Vasallo, C.G. Victora, and S. Teuchmann Mate drinking, alcohol, tobacco, diet, and esophageal cancer in Uruguay Cancer Res. 50 1990 426 431
20. C.G. Victora, N. Munoz, N.E. Day, L.B. Barcelos, D.A. Peccin, and N.M. Braga Hot beverages and oesophageal cancer in southern Brazil: a case-control study Int. J. Cancer 39 1987 710 716
21. X. Castellsague, N. Munoz, E. De Stefani, C.G. Victora, R. Castelletto, P.A. Rolon, and M.J. Quintana Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women Int. J. Cancer 82 1999 657 664
22. X. Castellsague, N. Munoz, E. De Stefani, C.G. Victora, M.J. Quintana, R. Castelletto, and P.A. Rolon Smoking and drinking cessation and risk of esophageal cancer (Spain) Cancer Causes Control 11 2000 813 818
23. X. Castellsague, N. Munoz, E. De Stefani, C.G. Victora, R. Castelletto, and P.A. Rolon Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America Int. J. Cancer 88 2000 658 664
24. E.L. Franco, L.P. Kowalski, B.V. Oliveira, M.P. Curado, R.N. Pereira, M.E. Silva, A.S. Fava, and H. Torloni Risk factors for oral cancer in Brazil: a case-control study Int. J. Cancer 43 1989 992 1000
25. S. Arrossi, R. Sankaranarayanan, and D.M. Parkin Incidence and mortality of cervical cancer in Latin America Salud Publica Mex. 45 Suppl. 3 2003 S306 S314
26. J. Eluf-Neto Number of sexual partners and smoking behaviour as risk factors for cervical dysplasia: comments on the evaluation of interaction Int. J. Epidemiol. 23 1994 1101 1104
27. J. Eluf-Neto, and C.M. Nascimento Cervical cancer in Latin America Semin. Oncol. 28 2001 188 197
28. N. Munoz Human papillomavirus and cancer: the epidemiological evidence J. Clin. Virol. 19 2000 1 5
29. M.R. Pillai, S. Lakshmi, S. Sreekala, T.G. Devi, P.G. Jayaprakash, T.N. Rajalakshmi, C.G. Devi, M.K. Nair, and M.B. Nair High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix Pathobiology 66 1998 240 246
30. L.A. Fonseca, A.S. Ramacciotti, and N.J. Eluf Mortality trends from uterine cervical cancer in the city of Sao Paulo from 1980 to 1999 Cad. Saude Publica 20 2004 136 142
31. S.C. Robles, and E. Galanis Breast cancer in Latin America and the Caribbean Rev. Panam. Salud Publica 11 2002 178 185
32. A.N. Hedeen, and E. White Breast cancer size and stage in Hispanic American women, by birthplace: 1992-1995 Am. J. Public Health 91 2001 122 125
33. F.P. Perera Molecular epidemiology: on the path to prevention? J. Natl. Cancer Inst. 92 2000 602 612
34. F.P. Perera, and I.B. Weinstein Molecular epidemiology: recent advances and future directions Carcinogenesis 21 2000 517 524
35. M. Kaghad, H. Bonnet, A. Yang, L. Creancier, J.C. Biscan, A. Valent, A. Minty, P. Chalon, J.M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 90 1997 809 819
36. S. Matsuura, H. Tauchi, A. Nakamura, N. Kondo, S. Sakamoto, S. Endo, D. Smeets, B. Solder, B.H. Belohradsky, K.V. Der, M. Oshimura, M. Isomura, Y. Nakamura, and K. Komatsu Positional cloning of the gene for Nijmegen breakage syndrome Nat. Genet. 19 1998 179 181
37. A. Yang, M. Kaghad, Y. Wang, E. Gillett, M.D. Fleming, V. Dotsch, N.C. Andrews, D. Caput, and F. McKeon p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol. Cell 2 1998 305 316
38. P. Hainaut, and M. Hollstein p53 and human cancer: the first ten thousand mutations Adv Cancer Res 77 2000 81 137
39. L.A. Donehower, M. Harvey, B.L. Slagle, M.J. McArthur, C.A.J. Montgomery, J.S. Butel, and A. Bradley Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 356 1992 215 221
40. M.L. Jungman Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress Neoplasia 2 2000 208 225
41. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
42. C. Cadwell, and G.P. Zambetti The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth Gene 277 2001 15 30
43. S. Ambs, S.P. Hussain, and C.C. Harris Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression FASEB J. 11 1997 443 448
44. H. Ohshima, and H. Bartsch Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis Mutat. Res. 305 1994 253 264
45. S. Ambs, W.P. Bennett, W.G. Merriam, M.O. Ogunfusika, S.M. Oser, A.M. Harrington, P.G. Shields, E. Felley-Bosco, S.P. Hussain, and C.C. Harris Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer J. Natl. Cancer Inst. 91 1999 86 88
46. J.A. Pietenpol, T. Tokino, S. Thiagalingam, W.S. El-Deiry, K.W. Kinzler, and B. Vogelstein Sequence-specific transcriptional activation is essential for growth suppression by p53 Proc. Natl. Acad. Sci. U.S.A. 91 1994 1998 2002
47. S. Kato, S.Y. Han, W. Liu, K. Otsuka, H. Shibata, R. Kanamaru, and C. Ishioka Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis Proc. Natl. Acad. Sci. U.S.A. 100 2003 8424 8429
48. M.A. Resnick, and A. Inga Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity Proc. Natl. Acad. Sci. U.S.A. 100 2003 9934 9939
49. F.P. Li, and J.F. Fraumeni Jr. Collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome Cancer Epidemiol. Biomarkers Prev. 3 1994 715 717
50. J.M. Birch, V. Blair, A.M. Kelsey, D.G. Evans, M. Harris, K.J. Tricker, and J.M. Varley Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome Oncogene 17 1998 1061 1068
51. J.M. Varley, M. Thorncroft, G. McGown, J. Appleby, A.M. Kelsey, K.J. Tricker, D.G. Evans, and J.M. Birch A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene Oncogene 14 1997 865 871
52. J.M. Boyle, E.L. Mitchell, M.J. Greaves, S.A. Roberts, K. Tricker, E. Burt, J.M. Varley, J.M. Birch, and D. Scott Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families Br. J. Cancer 77 1998 2181 2192
53. M. Olivier, D.E. Goldgar, N. Sodha, H. Ohgaki, P. Kleihues, P. Hainaut, and R.A. Eeles Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype Cancer Res. 63 2003 6643 6650
54. P. May, and E. May Twenty years of p53 research: structural and functional aspects of the p53 protein Oncogene 18 1999 7621 7636
55. G. Beckman, R. Birgander, A. Sjalander, N. Saha, P.A. Holmberg, A. Kivela, and L. Beckman Is p53 polymorphism maintained by natural selection? Hum. Hered. 44 1994 266 270
56. A. Storey, M. Thomas, A. Kalita, C. Harwood, D. Gardiol, F. Mantovani, J. Breuer, I.M. Leigh, G. Matlashewski, and L. Banks Role of a p53 polymorphism in the development of human papillomavirus-associated cancer Nature 393 1998 229 234
57. D.G. Peixoto, L.S. Hsin, P. Snijders, R. Wilmotte, R. Herrero, G. Lenoir, R. Montesano, C.J. Meijer, J. Walboomers, and P. Hainaut Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China Cancer Lett. 162 2001 231 235
58. A. Langerod, I.R. Bukholm, A. Bregard, P.E. Lonning, T.I. Andersen, T.O. Rognum, G.I. Meling, R.A. Lothe, and A.L. Borresen-Dale The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas Cancer Epidemiol. Biomarkers Prev. 11 2002 1684 1688
59. T.A. Simao, F.S. Ribeiro, L.M. Amorim, R.M. Albano, M.J. Andrada-Serpa, L.E. Cardoso, G.A. Mendonca, and C.V. Moura-Gallo TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: association with risk factors and tumor characteristics Int. J. Cancer 101 2002 69 73
60. M.A. Nagai, B.H. Schaer, M.A. Zago, S.W. Araujo Jr., I.N. Nishimoto, S. Salaorni, L.N. Guerreiro Costa, A.M. Silva, A.G. Caldas Oliveira, N.M. Mourao, and M.M. Brentani TP53 mutations in primary breast carcinomas from white and African-Brazilian patients Int. J. Oncol. 23 2003 189 196
61. F. Biramijamal, A. Allameh, P. Mirbod, H.J. Groene, R. Koomagi, and M. Hollstein Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran Cancer Res. 61 2001 3119 3123
62. A. Sepehr, P. Taniere, G. Martel-Planche, A.A. Zia'ee, F. Rastgar-Jazii, M. Yazdanbod, G. Etemad-Moghadam, F. Kamangar, F. Saidi, and P. Hainaut Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran Oncogene 20 2001 7368 7374
63. P. Taniere, G. Martel-Planche, P. Puttawibul, A. Casson, R. Montesano, A. Chanvitan, and P. Hainaut TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand Int. J. Cancer 88 2000 223 227
64. Y.Y. Liang, A. Esteve, G. Martel-Planche, S. Takahashi, S.H. Lu, R. Montesano, and M. Hollstein p53 mutations in esophageal tumors from high-incidence areas of China Int. J. Cancer 61 1995 611 614
65. J.A. Brennan, J.O. Boyle, W.M. Koch, S.N. Goodman, R.H. Hruban, Y.J. Eby, M.J. Couch, A.A. Forastiere, and D. Sidransky Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck N. Engl. J. Med. 332 1995 712 717
66. M.P. Tabor, R.H. Brakenhoff, V.M. van Houten, J.A. Kummer, M.H. Snel, P.J. Snijders, G.B. Snow, C.R. Leemans, and B.J. Braakhuis Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications Clin. Cancer Res. 7 2001 1523 1532
67. L.E. Moore, A.H. Smith, C. Eng, S. DeVries, D. Kalman, V. Bhargava, K. Chew, C. Ferreccio, O.A. Rey, C. Hopenhayn, M.L. Biggs, M.N. Bates, and F.M. Waldman P53 alterations in bladder tumors from arsenic and tobacco exposed patients Carcinogenesis 24 2003 1785 1791
68. S.B. Verghis, J.M. Essigmann, F.F. Kadlubar, M.L. Morningstar, and D.D. Lasko Specificity of mutagenesis by 4-aminobiphenyl: mutations at G residues in bacteriophage M13 DNA and G → C transversions at a unique dG(8-ABP) lesion in single-stranded DNA Carcinogenesis 18 1997 2403 2414
69. W. Warren, P.J. Biggs, M. el-Baz, M.A. Ghoneim, M.R. Stratton, and S. Venitt Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours Carcinogenesis 16 1995 1181 1189
70. C. Steinmaus, Y. Yuan, M.N. Bates, and A.H. Smith Case-control study of bladder cancer and drinking water arsenic in the western United States Am. J. Epidemiol. 158 2003 1193 1201
71. R.C. Ribeiro, F. Sandrini, B. Figueiredo, G.P. Zambetti, E. Michalkiewicz, A.R. Lafferty, L. DeLacerda, M. Rabin, C. Cadwell, G. Sampaio, I. Cat, C.A. Stratakis, and R. Sandrini An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma Proc. Natl. Acad. Sci. U.S.A. 98 2001 9330 9335
72. E.L. DiGiammarino, A.S. Lee, C. Cadwell, W. Zhang, B. Bothner, R.C. Ribeiro, G. Zambetti, and R.W. Kriwacki A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer Nat. Struct. Biol. 9 2002 12 16
73. M.C. Abba, L.M. Villaverde, M.A. Gomez, F.N. Dulout, M.R. Laguens, and C.D. Golijow The p53 codon 72 genotypes in HPV infection and cervical disease Eur. J. Obstet. Gynecol. Reprod. Biol. 109 2003 63 66
74. S.J. Klug, R. Wilmotte, C. Santos, M. Almonte, R. Herrero, I. Guerrero, E. Caceres, D. Peixoto-Guimaraes, G. Lenoir, P. Hainaut, J.M. Walboomers, and N. Munoz TP53 polymorphism, HPV infection, and risk of cervical cancer Cancer Epidemiol. Biomarkers Prev. 10 2001 1009 1012
75. A.E. Suarez-Rincon, M.C. Moran-Moguel, H. Montoya-Fuentes, M.P. Gallegos-Arreola, and J. Sanchez-Corona Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico Ginecol. Obstet. Mex. 70 2002 344 348
76. P.S. Araujo Souza, and L.L. Villa Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil Mutat. Res. 544 2003 375 383
77. S.M. Brenna, I.D. Silva, L.C. Zeferino, J.S. Pereira, E.Z. Martinez, and K.J. Syrjanen Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil Gynecol. Oncol. 93 2004 374 380
78. W.R. de Oliveira, P.L. Rady, J. Grady, T.K. Hughes, C.F. Neto, E.A. Rivitti, and S.K. Tyring Association of p53 arginine polymorphism with skin cancer Int. J. Dermatol. 43 2004 489 493
79. S.N. Drummond, L. De Marco, I.A. Pordeus, A.A. Barbosa, and R.S. Gomez TP53 codon 72 polymorphism in oral squamous cell carcinoma Anticancer Res. 22 2002 3379 3381
80. F. Granja, J. Morari, E.C. Morari, L.A. Correa, L.V. Assumpcao, and L.S. Ward Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer Cancer Lett. 210 2004 151 157
81. P.A. Gaspar, M.H. Hutz, F.M. Salzano, and T.A. Weimer TP53 polymorphisms and haplotypes in South Amerindians and neo-Brazilians Ann. Hum. Biol. 28 2001 184 194
82. M. Dai, G.M. Clifford, F. le Calvez, X. Castellsague, P.J. Snijders, M. Pawlita, R. Herrero, P. Hainaut, and S. Franceschi Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study Cancer Res. 64 2004 468 471
83. C. Casse, Y.C. Hu, and S.A. Ahrendt The XRCC1 codon 399 Gln allele is associated with adenine to guanine p53 mutations in non-small cell lung cancer Mutat. Res. 528 2003 19 27
84. S.A. Vayego-Lourenco TP53 mutations in a recurrent unicameral bone cyst Cancer Genet. Cytogenet. 124 2001 175 176
85. R. Manhani, L.M. Cristofani, F. Odone, and V.I. Bendit Concomitant p53 mutation and MYCN amplification in neuroblastoma Med. Pediatr. Oncol. 29 1997 206 207
86. N.A. Pinheiro, and L.L. Villa Low frequency of p53 mutations in cervical carcinomas among Brazilian women Braz. J. Med. Biol. Res. 34 2001 727 733
87. L. Yamamoto, A.A. Lopes, A. Harb-Gama, and M.A. Nagai TP53 mutations and loss of heterozygosity of chromosome 17 in colorectal tumors Braz. J. Genet. 19 1996 647 653
88. J.C. Roa, I. Roa, A. Melo, J.C. Araya, M.A. Villaseca, M. Flores, and B. Schneider p53 gene mutation in colorectal cancer Rev. Med. Chil. 128 2000 996 1004
89. A.V. Safatle-Ribeiro, U. Ribeiro Jr., P. Sakai, M.R. Clarke, S.N. Fylyk, S. Ishioka, J. Gama-Rodrigues, S.D. Finkelstein, and J.C. Reynolds Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus Cancer Detect. Prev. 24 2000 13 23
90. A. Putz, A.A. Hartmann, P.R. Fontes, C.O. Alexandre, D.A. Silveira, S.J. Klug, and H.M. Rabes TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors Int. J. Cancer 98 2002 99 105
91. M.C. Hollstein, L. Peri, A.M. Mandard, J.A. Welsh, R. Montesano, R.A. Metcalf, M. Bak, and C.C. Harris Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations Cancer Res. 51 1991 4102 4106
92. N. Yokoyama, J. Hitomi, H. Watanabe, Y. Ajioka, M. Pruyas, I. Serra, Y. Shirai, and K. Hatakeyama Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile Cancer Epidemiol. Biomarkers Prev. 7 1998 297 301
93. I. Roa, A. Melo, J. Roa, J. Araya, M. Villaseca, A. De X., P53 gene mutation in gallbladder cancer, Rev. Med. Chil. 128 (2000) 251-258.
94. M.A. Nagai, E.C. Miracca, L. Yamamoto, R.P. Moura, A.J. Simpson, L.P. Kowalski, and R.R. Brentani TP53 genetic alterations in head-and-neck carcinomas from Brazil Int. J. Cancer 76 1998 13 18
95. K.G. Bhatia, M.I. Gutierrez, K. Huppi, D. Siwarski, and I.T. Magrath The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors Cancer Res. 52 1992 4273 4276
96. C.E. Klumb, D.R. Furtado, L.M. de Resende, M.K. Carrico, A.M. Coelho, E. de Meis, R.C. Maia, and F.D. Rumjanek DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications Eur. J. Haematol. 71 2003 81 90
97. Y. Soini, S.C. Chia, W.P. Bennett, J.D. Groopman, J.S. Wang, V.M. DeBenedetti, H. Cawley, J.A. Welsh, C. Hansen, N.V. Bergasa, E.A. Jones, A.M. DiBisceglie, G.E. Trivers, C.A. Sandoval, I.E. Calderon, L.E. Munoz Espinosa, and C.C. Harris An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico Carcinogenesis 17 1996 1007 1012
98. L. Quintanilla-Martinez, M. Kremer, G. Keller, M. Nathrath, A. Gamboa-Dominguez, A. Meneses, L. Luna-Contreras, A. Cabras, H. Hoefler, A. Mohar, and F. Fend p53 mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease Am. J. Pathol. 159 2001 2095 2105
99. J.E. Levi, P. Rahal, A.S. Sarkis, and L. Villa Human papillomavirus DNA and p53 status in penile carcinomas Int. J. Cancer 76 1998 779 783
100. A.V. Safatle-Ribeiro, J.U. Ribeiro, J.C. Reynolds, J.J. Gama-Rodrigues, K. Iriya, R. Kim, A. Bakker, P.A. Swalsky, H.W. Pinotti, and S.D. Finkelstein Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach Cancer 78 1996 2288 2299